title: Letter by Nikpour et al Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)".
authors.affiliation: The University of Melbourne at St. Vincent's Hospital Melbourne Australia.
authors.forename: Mandana
authors.initials: M
authors.lastname: Nikpour
authors.affiliation: The University of Melbourne at St. Vincent's Hospital Melbourne Australia.
authors.forename: David
authors.initials: D
authors.lastname: Prior
authors.affiliation: The University of Sydney at Royal Prince Alfred Hospital Sydney Australia.
authors.forename: David
authors.initials: D
authors.lastname: Celermajer
mesh_terms: D019468:Disease Management; D065627:Familial Primary Pulmonary Hypertension; D006801:Humans; D006976:Hypertension, Pulmonary; D012042:Registries; D015996:Survival Rate; D014859:Warfarin
chemical_list: D014859:Warfarin